DEUTSCHE BANK AG\ - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 14 filers reported holding AKARI THERAPEUTICS PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q4 2019$1,000
-99.6%
1,027
-99.2%
0.00%
Q2 2019$266,000
+291.2%
132,000
+594.7%
0.00%
Q1 2019$68,000
+423.1%
19,000
+493.8%
0.00%
Q4 2017$13,000
-59.4%
3,200
-39.6%
0.00%
Q3 2017$32,000
+433.3%
5,300
+278.6%
0.00%
Q2 2017$6,000
-97.7%
1,400
-94.0%
0.00%
Q1 2017$258,000
+57.3%
23,3870.0%0.00%
Q4 2016$164,000
-17.6%
23,3870.0%0.00%
Q3 2016$199,000
-36.8%
23,3870.0%0.00%
Q2 2016$315,000
+34.0%
23,3870.0%0.00%
Q1 2016$235,000
-17.8%
23,387
+18.2%
0.00%
Q4 2015$286,00019,7870.00%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q4 2019
NameSharesValueWeighting ↓
VHCP Management II, LLC 369,490$3,144,0001.61%
Vivo Capital, LLC 527,842$4,492,0001.40%
VHCP Management, LLC 158,352$1,348,0001.33%
Foresite Capital Management III, LLC 197,072$1,677,0000.78%
Boxer Capital, LLC 139,899$1,191,0000.53%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,150,700$9,792,0000.46%
NEA Management Company, LLC 452,167$3,848,0000.17%
RA Capital Management 114,039$970,0000.10%
ACUTA CAPITAL PARTNERS, LLC 23,169$197,0000.07%
QVT Financial LP 263,921$1,833,0000.07%
View complete list of AKARI THERAPEUTICS PLC shareholders